Eli Lilly's tirzepatide has been shown to significantly cut cardiovascular risks in patients with obesity and a form of heart failure with few treatment options, in another big win for the GLP-1 ...

Eli Lilly's latest clinical readout for dual GIP/GLP-1 agonist tirzepatide is a big one, with data suggesting the drug can reduce the risk of developing type 2 diabetes in overweight and obese ...

In 1958, Francis Crick's sequence hypothesis finally provided an answer to the question: what is a gene? Why is this definition now considered overly simplistic? Roberts and Sharp also noted that ...

This article was originally published with the title “ The Nucleotide Sequence of a Nucleic Acid ” in Scientific American Magazine Vol. 214 No. 2 (February 1966), p. 30 doi:10.1038 ...

Diabetes Care. 2013;36(4):1047-1055.